Compare AGIO & TNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGIO | TNK |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2013 | 2007 |
| Metric | AGIO | TNK |
|---|---|---|
| Price | $37.57 | $75.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $38.88 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 1.0M | 308.8K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,011,000.00 | N/A |
| Revenue This Year | $76.75 | N/A |
| Revenue Next Year | $170.73 | N/A |
| P/E Ratio | ★ N/A | $8.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.24 | $41.77 |
| 52 Week High | $46.00 | $83.99 |
| Indicator | AGIO | TNK |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 55.86 |
| Support Level | $26.71 | $70.54 |
| Resistance Level | $44.01 | $80.29 |
| Average True Range (ATR) | 1.69 | 2.47 |
| MACD | -0.77 | 0.70 |
| Stochastic Oscillator | 27.89 | 77.90 |
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.
Teekay Tankers Ltd is a provider of marine services to the international oil and natural gas industries and an operator of medium-sized oil tankers. The company operates in two segments: Tankers, which consists of the operation of all of the company's tankers (including the operations from those tankers employed on full service lightering contracts), and the company's U.S. based ship-to-ship support service operations (including its lightering support services provided as part of full service lightering operations); and Marine Services, which consists of operational and maintenance marine services provided to the Australian government, Australian energy companies and other third parties. The company generates the majority of its revenue from the Tankers segment.